Ms. Daste will head LEO Pharma’s Global People function as well as Corporate Affairs.

Nathalie Daste is LEO Pharma’s new Executive Vice President, Global People and Corporate Affairs, and member of its Global Leadership Team, effective October 1, 2023.

In her new role, Ms. Daste will head LEO Pharma’s Global People function as well as Corporate Affairs, including sustainability and ESG. She succeeds Dennis Schmidt Pedersen, who has decided to step down from his role and leave LEO Pharma after six years in the company.

Ms. Daste holds an MBA from INSEAD, France, and a master’s degree in management from ESSEC, France. She has worked ar Novartis and McKinsey & Company and was recently Chief People Officer, Global Head Strategy & Commercial Excellence at CENTOGENE.

“I am looking very much forward to welcoming Nathalie Daste to the LEO Pharma family. Her vast experience from global life-science makes her a catch for LEO Pharma as we have been looking for a successor to Dennis Schmidt Pedersen,” says Christophe Bourdon, CEO of LEO Pharma,in a news release. “Nathalie brings a strong external view and experience from developing and leading people to LEO Pharma.”

Ms. Daste adds, “I am truly excited to be joining LEO Pharma and becoming part of the amazing journey the company is on, helping people suffering from skin diseases”